The Cardiology Advisor

ACC Issues Statement on Direct Oral Anticoagulants for Thrombotic Event Prevention

The American College of Cardiology issued a 2026 scientific statement on direct oral anticoagulants for the prevention of thrombotic events.

Mutant Rodents Are Developing Rat Poison Resistance

And over a third (35%) of the team’s 143 Norway rat specimens (Rattus norvegicus), all sourced from those same northeastern ...
European Medical Journal

Review of the European Renal Association (ERA) Congress 2026

THE QUAINT city of Glasgow provided the backdrop for Europe’s premier nephrology meeting, the 63rd annual European Renal ...
Le Lézard

LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an ...

Eisai Co., Ltd. and Biogen Inc. announced today that results from the real-world Lecanemab in Early Alzheimer's Disease (LEADER) Study show that nearly 83% of early Alzheimer's disease (AD) patients ...
The Lancet

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-labe…

Among patients with atrial fibrillation and predominantly chronic coronary syndrome undergoing PCI with intravascular imaging ...

Johnson & Johnson (JNJ) Q2 2026 Earnings Call Transcript

Q2 2026 Earnings Call July 15, 2026 8:30 AM EDTCompany ParticipantsRyan KoorsJoaquin Duato - CEO & ChairmanJoseph Wolk ...